Journal of Cancer Research and Therapeutics

Papers
(The H4-Index of Journal of Cancer Research and Therapeutics is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
ALDH1 Immunohistochemical expression and its association with tumor budding in oral squamous cell carcinoma of gingivobuccal complex37
Ampullary mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) is an exceptionally rare case presenting as abdominal pain35
Analysis of the gamma index using an indigenously developed anthropomorphic heterogeneous female pelvis (AHFP) phantom30
Impact of immobilization devices on the inter-fractional setup error and planning target volume for pelvic radiation therapy30
Definitive radiotherapy with nodal boost for radiologically positive nodes in carcinoma cervix – A retrospective cohort study26
Importance of radio-histo-cytopathological correlation, A retrospective study of cyto-histological and radiological correlation of salivary gland lesions using Milan System for Reporting Salivary Glan25
Origin and survival outcomes of Pseudomyxoma peritonei—A retrospective study21
Cost analysis of anticancer chemotherapy and chemoirradiation regimens considering the drugs marketed through Jan Aushadhi (People’s Medicine) stores and their branded counterparts: First cost compari19
Outcomes with optimal treatment in geriatric head and neck cancers – Tertiary cancer centre experience16
Pilot study of radiation oncology peer review in low middle income country (LMIC) through cloud-based platform14
Polymorphous adenocarcinoma of the buccal space—Rare, reported case from our institute14
Expression of stem cell biomarker CD44 in oral squamous cell carcinoma and its association with lymph node metastasis and TNM staging14
Evaluation of salivary endothelin-1 as a biomarker for oral cancer and precancer13
A study on the antitumor effect of gemcitabine polybutylcy- anoacrylate nanoparticles coupled with Mucin 1 monoclonal antibody on pancreatic cancer in vitro and in vivo13
0.10124897956848